Plain-English translation of NCT05937958 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a new way to deliver radiation therapy called MRLinac boost for patients with advanced cervical cancer who cannot receive a standard treatment called brachytherapy. MRLinac uses advanced MRI imaging combined with radiation to target the tumor more precisely. The goal is to see if this newer approach works as well as the traditional method while potentially reducing side effects to healthy tissues nearby.
Some cervical cancer patients cannot safely receive brachytherapy due to their individual circumstances. This trial exists to find out if this newer radiation technique can be an effective alternative that uses better imaging to protect surrounding healthy organs while still treating the cancer effectively.
You likely qualify if…
You likely don't qualify if…
You would receive a course of external beam radiation therapy combined with chemotherapy, followed by MRLinac boost treatments instead of traditional brachytherapy. Before and sometimes during each radiation session, you would have MRI scans to help the doctors see your tumor and surrounding organs, and they may adjust your treatment plan based on what they see. Your progress would be carefully tracked and monitored as part of a multicenter research study across several hospitals.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
Denmark
Netherlands